Prulifloxacin in Chronic Bacterial Prostatitis (CBP)

NCT03201796 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Bacterial Prostatitis

Interventions

DRUG: Prulifloxacin 600 mg
DRUG: Levofloxacin 500mg

Sponsor

Aziende Chimiche Riunite Angelini Francesco S.p.A

Collaborators

[object Object]